Cargando…
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment for the active phase of moderate to severe Graves' orbitopathy (GO). However, acute and severe liver damage has been reported during and after IVMP therapy. In this retrospective study, we investigated risk factors...
Autores principales: | Eguchi, Hiroyuki, Tani, Junichi, Hirao, Saori, Tsuruta, Munehisa, Tokubuchi, Ichiro, Yamada, Kentaro, Kasaoka, Masataka, Teshima, Yasuo, Kakuma, Tatsuyuki, Hiromatsu, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499413/ https://www.ncbi.nlm.nih.gov/pubmed/26221141 http://dx.doi.org/10.1155/2015/835979 |
Ejemplares similares
-
Graves' Orbitopathy
por: Hiromatsu, Yuji, et al.
Publicado: (2015) -
Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2019) -
High-dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII
por: Miśkiewicz, P., et al.
Publicado: (2018) -
Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018) -
Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
por: Rymuza, Joanna, et al.
Publicado: (2022)